Skip to content 
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. It also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, the company provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. It provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana. more
| Time Frame | ELV | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | -3.04% | 0.14% | 0.86% |
| 1-Month Return | -11.93% | -0.72% | -0.47% |
| 3-Month Return | 4.76% | 3.7% | 1.34% |
| 6-Month Return | 13.57% | 19.92% | 8.86% |
| 1-Year Return | -15.58% | 7% | 14.32% |
| 3-Year Return | -33.31% | 16.96% | 67.75% |
| 5-Year Return | 12.77% | 34.22% | 77.15% |
| 10-Year Return | 175.25% | 145.99% | 279.46% |
| Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | 138.64B | 156.59B | 171.34B | 176.81B | 199.13B | [{"date":"2021-12-31","value":69.62,"profit":true},{"date":"2022-12-31","value":78.64,"profit":true},{"date":"2023-12-31","value":86.05,"profit":true},{"date":"2024-12-31","value":88.79,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Cost of Revenue | 102.64B | 116.64B | 124.33B | 127.57B | 148.22B | [{"date":"2021-12-31","value":69.25,"profit":true},{"date":"2022-12-31","value":78.69,"profit":true},{"date":"2023-12-31","value":83.88,"profit":true},{"date":"2024-12-31","value":86.06,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Gross Profit | 35.99B | 39.95B | 47.01B | 49.24B | 50.90B | [{"date":"2021-12-31","value":70.71,"profit":true},{"date":"2022-12-31","value":78.49,"profit":true},{"date":"2023-12-31","value":92.35,"profit":true},{"date":"2024-12-31","value":96.74,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Gross Margin | 25.96% | 25.51% | 27.44% | 27.85% | 25.56% | [{"date":"2021-12-31","value":93.22,"profit":true},{"date":"2022-12-31","value":91.61,"profit":true},{"date":"2023-12-31","value":98.51,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":91.78,"profit":true}] |
| Operating Expenses | 27.05B | 31.50B | 38.27B | 40.35B | 42.79B | [{"date":"2021-12-31","value":63.21,"profit":true},{"date":"2022-12-31","value":73.62,"profit":true},{"date":"2023-12-31","value":89.43,"profit":true},{"date":"2024-12-31","value":94.31,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Operating Income | 8.95B | 8.45B | 8.74B | 8.89B | 8.11B | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":94.47,"profit":true},{"date":"2023-12-31","value":97.75,"profit":true},{"date":"2024-12-31","value":99.35,"profit":true},{"date":"2025-12-31","value":90.68,"profit":true}] |
| Total Non-Operating Income/Expense | (1.82B) | (1.70B) | (2.03B) | (2.17B) | (2.80B) | [{"date":"2021-12-31","value":-181900000000,"profit":false},{"date":"2022-12-31","value":-170200000000,"profit":false},{"date":"2023-12-31","value":-203000000000,"profit":false},{"date":"2024-12-31","value":-216900000000,"profit":false},{"date":"2025-12-31","value":-280400000000,"profit":false}] |
| Pre-Tax Income | 7.92B | 7.60B | 7.71B | 7.90B | 6.71B | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":95.9,"profit":true},{"date":"2023-12-31","value":97.35,"profit":true},{"date":"2024-12-31","value":99.74,"profit":true},{"date":"2025-12-31","value":84.67,"profit":true}] |
| Income Taxes | 1.83B | 1.71B | 1.72B | 1.93B | 1.05B | [{"date":"2021-12-31","value":94.67,"profit":true},{"date":"2022-12-31","value":88.57,"profit":true},{"date":"2023-12-31","value":89.19,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":54.27,"profit":true}] |
| Income After Taxes | 6.09B | 5.89B | 5.99B | 5.97B | 5.66B | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":96.6,"profit":true},{"date":"2023-12-31","value":98.29,"profit":true},{"date":"2024-12-31","value":97.97,"profit":true},{"date":"2025-12-31","value":92.88,"profit":true}] |
| Income From Continuous Operations | 6.09B | 6.02B | 6.17B | 5.97B | 5.66B | [{"date":"2021-12-31","value":98.82,"profit":true},{"date":"2022-12-31","value":97.58,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":96.81,"profit":true},{"date":"2025-12-31","value":91.78,"profit":true}] |
| Income From Discontinued Operations | - | - | - | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Net Income | 6.10B | 5.89B | 5.99B | 5.98B | 5.66B | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":96.56,"profit":true},{"date":"2023-12-31","value":98.08,"profit":true},{"date":"2024-12-31","value":97.97,"profit":true},{"date":"2025-12-31","value":92.76,"profit":true}] |
| EPS (Diluted) | 25.97 | 29.05 | 33.11 | 32.97 | 30.17 | [{"date":"2021-12-31","value":78.44,"profit":true},{"date":"2022-12-31","value":87.74,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":99.58,"profit":true},{"date":"2025-12-31","value":91.12,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
| ELV | |
|---|---|
| Cash Ratio | 0.23 |
| Current Ratio | 1.54 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| ELV | |
|---|---|
| ROA (LTM) | 4.35% |
| ROE (LTM) | 13.25% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| ELV | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.64 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.36 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| ELV | |
|---|---|
| Trailing PE | 12.92 |
| Forward PE | 12.30 |
| P/S (TTM) | 0.36 |
| P/B | 1.64 |
| Price/FCF | NM |
| EV/R | 0.47 |
| EV/Ebitda | NM |
| PEG | 1.27 |
Elevance Health Inc (ELV) share price today is $342.37
Yes, Indians can buy shares of Elevance Health Inc (ELV) on Vested. To buy
Yes, you can purchase fractional shares of Elevance Health Inc (ELV) via the Vested app. You can start investing in Elevance Health Inc (ELV) with a minimum investment of $1.
You can invest in shares of Elevance Health Inc (ELV) via Vested in three simple steps:
The 52-week high price of Elevance Health Inc (ELV) is $451.93. The 52-week low price of Elevance Health Inc (ELV) is $270.83.
The price-to-earnings (P/E) ratio of Elevance Health Inc (ELV) is 12.9222
The price-to-book (P/B) ratio of Elevance Health Inc (ELV) is 1.64
The dividend yield of Elevance Health Inc (ELV) is 2.09%
The market capitalization of Elevance Health Inc (ELV) is $72.89B
The stock symbol (or ticker) of Elevance Health Inc is ELV
Consider the share price of Elevance Health Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Elevance Health Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Elevance Health Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Elevance Health Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Elevance Health Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Elevance Health Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
